CORD-19:68a7101a90454172c91785d8c352f776a82df5d4 / 712865-713074 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/68a7101a90454172c91785d8c352f776a82df5d4","sourcedb":"CORD-19","sourceid":"68a7101a90454172c91785d8c352f776a82df5d4","text":"Ongoing screening of glycolipid antibody present within patient CSF and PB detected relatively strong levels of anti-GM2, GD1b, and GQ1b antibodies which varied between compartment assayed and patient samples.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T35030","span":{"begin":0,"end":209},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T35030","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T130","span":{"begin":0,"end":209},"obj":"Sentence"}],"attributes":[{"subj":"T130","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T2993","span":{"begin":64,"end":67},"obj":"Body_part"}],"attributes":[{"id":"A2993","pred":"uberon_id","subj":"T2993","obj":"http://purl.obolibrary.org/obo/UBERON_0001359"},{"subj":"T2993","pred":"source","obj":"CORD-19-PD-UBERON"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T4458","span":{"begin":72,"end":74},"obj":"Disease"},{"id":"T97163","span":{"begin":72,"end":74},"obj":"Disease"}],"attributes":[{"id":"A4458","pred":"mondo_id","subj":"T4458","obj":"http://purl.obolibrary.org/obo/MONDO_0019035"},{"id":"A76802","pred":"mondo_id","subj":"T97163","obj":"http://purl.obolibrary.org/obo/MONDO_0019035"},{"subj":"T4458","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T97163","pred":"source","obj":"CORD-19-PD-MONDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#93e0ec","default":true},{"id":"CORD-19_Custom_license_subset","color":"#ecde93"},{"id":"CORD-19-PD-UBERON","color":"#c493ec"},{"id":"CORD-19-PD-MONDO","color":"#93ecaa"}]}]}}